Author:
Leader Shelah,Jacobson Phillip,Marcin James,Vardis Ralph,Sorrentino Mark,Murray Dennis
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference10 articles.
1. Update. Respiratory syncytial virus activity—United States, 1998–1999 season;Centers for Disease Control;MMWR Morb Mortal Wkly Rep,1999
2. Bronchiolitis-associated hospitalizations among US Children. 1980–96;Shay;JAMA,1999
3. Prevention of RSV infections: indications for use of palivizumab and update on the use of RSV-IGIV;American Academy of Pediatrics, Committee onInfectious Diseases, Committee on Fetus and Newborn;Pediatrics,1998
4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants;The Impact-RSV Study Group;Pediatrics,1998
5. Effectiveness of Palivizumab — evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season;Sorrentino;Pediatr Infect Dis J,2000
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献